111 related articles for article (PubMed ID: 1510942)
1. Evidence for the extent of insertion of the active site loop of intact alpha 1 proteinase inhibitor in beta-sheet A.
Schulze AJ; Frohnert PW; Engh RA; Huber R
Biochemistry; 1992 Aug; 31(33):7560-5. PubMed ID: 1510942
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways.
Hood DB; Huntington JA; Gettins PG
Biochemistry; 1994 Jul; 33(28):8538-47. PubMed ID: 8031789
[TBL] [Abstract][Full Text] [Related]
3. Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.
Schulze AJ; Baumann U; Knof S; Jaeger E; Huber R; Laurell CB
Eur J Biochem; 1990 Nov; 194(1):51-6. PubMed ID: 2253623
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activity and conformational transition of alpha 1-proteinase inhibitor variants.
Schulze AJ; Huber R; Degryse E; Speck D; Bischoff R
Eur J Biochem; 1991 Dec; 202(3):1147-55. PubMed ID: 1765073
[TBL] [Abstract][Full Text] [Related]
5. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
6. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
Björk I; Ylinenjärvi K; Olson ST; Bock PE
J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
[TBL] [Abstract][Full Text] [Related]
7. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes.
Perlmutter DH; Glover GI; Rivetna M; Schasteen CS; Fallon RJ
Proc Natl Acad Sci U S A; 1990 May; 87(10):3753-7. PubMed ID: 2160076
[TBL] [Abstract][Full Text] [Related]
8. Probing the local conformational change of alpha1-antitrypsin.
Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin.
James HL; Cohen AB
J Clin Invest; 1978 Dec; 62(6):1344-53. PubMed ID: 311784
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
11. alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition.
Dobó J; Gettins PG
J Biol Chem; 2004 Mar; 279(10):9264-9. PubMed ID: 14593107
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes of the alpha 1-proteinase inhibitor affecting its cholesterol binding ability.
Janciauskiene S; Eriksson S
FEBS Lett; 1993 Jun; 323(3):236-8. PubMed ID: 8500616
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
14. Trypsin complexed with alpha 1-proteinase inhibitor has an increased structural flexibility.
Kaslik G; Patthy A; Bálint M; Gráf L
FEBS Lett; 1995 Aug; 370(3):179-83. PubMed ID: 7656972
[TBL] [Abstract][Full Text] [Related]
15. Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.
Dementiev A; Dobó J; Gettins PG
J Biol Chem; 2006 Feb; 281(6):3452-7. PubMed ID: 16321984
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
Mast AE; Enghild JJ; Pizzo SV; Salvesen G
Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
Wei A; Rubin H; Cooperman BS; Christianson DW
Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
[TBL] [Abstract][Full Text] [Related]
18. Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidase.
Wallaert B; Gressier B; Aerts C; Mizon C; Voisin C; Mizon J
Am J Respir Cell Mol Biol; 1991 Nov; 5(5):437-44. PubMed ID: 1657063
[TBL] [Abstract][Full Text] [Related]
19. Influence of the P5 residue on alpha1-proteinase inhibitor mechanism.
Chaillan-Huntington CE; Patston PA
J Biol Chem; 1998 Feb; 273(8):4569-73. PubMed ID: 9468513
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
